WallStreetZenWallStreetZen

NASDAQ: NVCR
Novocure Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

NVCR past revenue growth

How has NVCR's revenue growth performed historically?
Company
-5.3%
Industry
9.37%
Market
17.55%
NVCR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NVCR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NVCR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NVCR earnings and revenue history

Current Revenue
$509.3M
Current Earnings
-$207.0M
Current Profit Margin
-40.6%

NVCR Return on Equity

Current Company
-51.6%
Current Industry
10.5%
Current Market
188%
NVCR's Return on Equity (-51.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NVCR announces earnings.

NVCR Return on Assets

Current Company
-17.9%
Current Industry
5.3%
NVCR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NVCR Return on Capital Employed

Current Company
-24.08%
Current Industry
8.3%
NVCR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NVCR vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NVCR$509.34M-$221.90M-$207.04M+15.47%N/A
AHCO$3.20B-$177.01M-$678.90M+35.28%N/A
ESTA$165.15M-$58.31M-$78.50M+21.96%N/A
INMD$492.05M$217.89M$197.92M+37.49%+42.03%
UFPT$400.07M$68.95M$44.92M+16.00%+24.74%
View Top Medical Device Stocks

NVCR earnings dates

Next earnings date
Jun 5, 2024

Novocure Earnings & Revenue FAQ

What were NVCR's earnings last quarter?

On Invalid Date, Novocure (NASDAQ: NVCR) reported Q4 2023 earnings per share (EPS) of -$0.44, up 25.71% year over year. Total Novocure earnings for the quarter were -$47.08 million. In the same quarter last year, Novocure's earnings per share (EPS) was -$0.35.

If you're new to stock investing, here's how to buy Novocure stock.

What was NVCR's earnings growth in the past year?

As of Q2 2024, Novocure's earnings has grown year over year. Novocure's earnings in the past year totalled -$207.04 million.

What is NVCR's earnings date?

Novocure's earnings date is Invalid Date. Add NVCR to your watchlist to be reminded of NVCR's next earnings announcement.

What was NVCR's revenue last quarter?

On Invalid Date, Novocure (NASDAQ: NVCR) reported Q4 2023 revenue of $133.78 million up 4.17% year over year. In the same quarter last year, Novocure's revenue was $128.43 million.

What was NVCR's revenue growth in the past year?

As of Q2 2024, Novocure's revenue has grown -5.3% year over year. This is 14.67 percentage points lower than the US Medical Devices industry revenue growth rate of 9.37%. Novocure's revenue in the past year totalled $509.34 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.